Charles T Post Jr, MD | |
40 Industrial Park Rd, Plymouth, MA 02360-4884 | |
(508) 746-8600 | |
(508) 747-1002 |
Full Name | Charles T Post Jr |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 40 Industrial Park Rd, Plymouth, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790753895 | NPI | - | NPPES |
5226517001 | Other | CIGNA | |
597692 | Other | AETNA HEALTHCARE | |
B33417 | Other | MA | BLUE CROSS/BLUE SHIELD |
29646 | Other | MA | BOSTON MEDICAL HEALTHNET |
2019302 | Medicaid | MA | |
150696 | Other | MA | HARVARD PILGRIM HEALTH |
035558 | Other | MA | TUFTS HEALTHCARE |
0800029 | Other | UNITED HEALTHCARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 35558 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Charles T Post Jr, MD 40 Industrial Park Rd, Plymouth, MA 02360-4884 Ph: (508) 746-8600 | Charles T Post Jr, MD 40 Industrial Park Rd, Plymouth, MA 02360-4884 Ph: (508) 746-8600 |
News Archive
For years, doctors have warned patients to finish their antibiotic prescriptions or risk a renewed infection by a "superbug" that can mount a more powerful defense against the same drug. But a new study by Boston University biomedical engineers indicates that treating bacteria with levels of antibiotics insufficient to kill them produces germs that are cross-resistant to a wide range of antibiotics.
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
Cytek Biosciences Inc., a leading provider of advanced flow cytometry instrumentation, today announced that its Quality Management System (QMS) has achieved ISO 9001:2015 certification.
An international research consortium including scientists from The University of Texas Health Science Center at Houston (UTHealth) has identified a new genetic link to the systemic form of scleroderma. Researchers believe a thorough understanding of the genetic nature of the disease is crucial to developing a cure.
Precision NanoSystems NanoAssemblr platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project.
› Verified 3 days ago
Eddie F Kadrmas, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-8600 Fax: 508-747-1002 | |
Daniel J O'connor, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 146 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-833-6000 Fax: 508-534-6060 | |
Shazia Saman Ahmed, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-6178 | |
Dr. Lois M Townshend, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 45 Resnik Rd, Suite 301, Plymouth, MA 02360 Phone: 508-747-4748 Fax: 508-747-0124 | |
Dr. Henry J Kriegstein, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 45 Resnik Rd, Suite 301, Plymouth, MA 02360 Phone: 508-747-4748 Fax: 508-747-0124 | |
Allan W. Berg, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 40 Industrial Park Rd, Plymouth, MA 02360 Phone: 508-746-8600 Fax: 508-747-1002 |